✦ LIBER ✦

Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study

✍ Scribed by G. Robinet; F. Barlesi; P. Fournel; H. Berard; R. Corre; A. Vergnenegre; L. Falchero; P-J. Souquet; A. Tisseron-Carrasco; C. Chouaid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin combined w

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase II study of weekly docetaxel combi

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase I study of second-line chemotherap

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

Combination therapy with docetaxel and l

✍ Jaime Feliu; Jose Luis Firvida; Javier Castro; Catherina Madroñal; Angeles Rodrí 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB

Phase II combination of gefitinib and do

✍ M. Gatineau; E. Dansin; F. Chomy; E. Lemarie; P. Nouyrigat; S. Oudard; R. Mouawa 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB